VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
Contacts
Inquiries
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
The post AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 appeared first on Daily Host News.
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 first appeared on Web and IT News.
Ford Motor Company sold fewer vehicles in the first quarter of 2025 than it did…
When Tim Cook was asked about Apple’s plans for smart glasses during a recent interview,…
Britain’s biggest banks are spending billions of pounds a year keeping decades-old technology alive —…
For decades, American brands carried an almost magnetic allure in China. Nike sneakers, Apple iPhones,…
Starbucks is about to do something it hasn’t done in its 54-year history: pay its…
Somewhere inside IBM’s sprawling research apparatus, engineers are working on something that would have seemed…
This website uses cookies.